10.50 - 11.12
3.81 - 12.83
1.80M / 1.61M (Avg.)
158.14 | 0.07
View analysts' price targets and recommendations, and compare them with competitors.
$4.18
Has downside compared to CGAU's upside of 39.95%.
Buy
Equal to CGAU's analyst recommendation of Buy.
Analyze analyst forecasts for the company and compare them with competitors.
232.80M
The estimated revenue has increased from the previous period.
64.27M
The estimated EBITDA has decreased from the previous period.
0.19
The estimated EPS has decreased from the previous period.
62.93M
The estimated net income has decreased from the previous period.
49.33M
The estimated EBIT has decreased from the previous period.
163.64M
The estimated SG&A expenses have decreased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
999.76M
Revenue has increased from the previous period.
41.92%
Revenue growth rate is unchanged from the previous period.
276.02M
EBITDA has increased from the previous period.
27.61%
EBITDA margin is unchanged from the previous period.
211.87M
EBIT has increased from the previous period.
21.19%
EBIT margin is unchanged from the previous period.
271.57M
Depreciation has increased from the previous period.
674.26M
Total cash has increased from the previous period.
67.44%
Cash percentage is unchanged from the previous period.
427.64M
Receivables have increased from the previous period.
42.77%
Receivables percentage is unchanged from the previous period.
464.86M
Inventories have increased from the previous period.
46.50%
Inventory percentage is unchanged from the previous period.
421.67M
Accounts payable has increased from the previous period.
42.18%
Payables percentage is unchanged from the previous period.
-253.19M
Capital expenditure has increased from the previous period.
-25.33%
CapEx percentage is unchanged from the previous period.
9.16%
WACC is unchanged from the previous period.
9.08%
Cost of equity is unchanged from the previous period.
293.12%
Cost of debt is unchanged from the previous period.
1.06
Beta is unchanged from the previous period.
333.90M
Diluted shares outstanding is unchanged from the previous period.
1.56M
Total debt is unchanged from the previous period.
3.49B
Total equity is unchanged from the previous period.
3.49B
Total capital is unchanged from the previous period.
0.04%
Debt weighting is unchanged from the previous period.
99.96%
Equity weighting is unchanged from the previous period.
130.88M
EBIAT has increased from the previous period.
10.18M
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
205.99M
Terminal value is unchanged from the previous period.
73.57M
Enterprise value is unchanged from the previous period.
-113.70M
Net debt is unchanged from the previous period.
187.27M
Equity value is unchanged from the previous period.
0.56
Equity value per share is unchanged from the previous period.
